LLY

1,020.07

-1.55%↓

JNJ

244.95

+0.71%↑

ABBV

228.53

-1.79%↓

NVS

165.17

-0.6%↓

MRK

121.6

+0.04%↑

LLY

1,020.07

-1.55%↓

JNJ

244.95

+0.71%↑

ABBV

228.53

-1.79%↓

NVS

165.17

-0.6%↓

MRK

121.6

+0.04%↑

LLY

1,020.07

-1.55%↓

JNJ

244.95

+0.71%↑

ABBV

228.53

-1.79%↓

NVS

165.17

-0.6%↓

MRK

121.6

+0.04%↑

LLY

1,020.07

-1.55%↓

JNJ

244.95

+0.71%↑

ABBV

228.53

-1.79%↓

NVS

165.17

-0.6%↓

MRK

121.6

+0.04%↑

LLY

1,020.07

-1.55%↓

JNJ

244.95

+0.71%↑

ABBV

228.53

-1.79%↓

NVS

165.17

-0.6%↓

MRK

121.6

+0.04%↑

Search

ICU Medical Inc

Fermé

SecteurSoins de santé

150.69 1.92

Résumé

Variation du prix de l'action

24h

Actuel

Min

146.12

Max

153.82

Chiffres clés

By Trading Economics

Revenu

-39M

-3.4M

Ventes

-12M

537M

Marge bénéficiaire

-0.632

Employés

15,000

EBITDA

-40M

67M

Recommandations

By TipRanks

Recommandations

Achat

Prévisions sur 12 Mois

+20.77% upside

Dividendes

By Dow Jones

Prochains Résultats

19 févr. 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

544M

3.6B

Ouverture précédente

148.77

Clôture précédente

150.69

Sentiment de l'Actualité

By Acuity

34%

66%

103 / 351 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Very Strong Bullish Evidence

ICU Medical Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

18 févr. 2026, 22:31 UTC

Résultats

Brambles Raises Dividend, Cash-Flow Guidance as 1st Half Profit Jumps -- Update

18 févr. 2026, 22:18 UTC

Résultats

Wal-Mart de Mexico 4Q Profit Falls, Hit by Higher Taxes

18 févr. 2026, 22:11 UTC

Résultats

Wesfarmers Boosts Dividend After 1st Half Profit Rises -- Update

18 févr. 2026, 21:52 UTC

Résultats

Telstra Boosts Dividend as First-Half Earnings Rise 5.5% -- Update

18 févr. 2026, 23:56 UTC

Market Talk

Santos's Review of Domestic Assets Could Lead to Simpler Portfolio -- Market Talk

18 févr. 2026, 23:46 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

18 févr. 2026, 23:46 UTC

Market Talk

Nikkei May Rise After U.S. Tech Stock Gains -- Market Talk

18 févr. 2026, 23:34 UTC

Market Talk
Résultats

Brambles' Cost Control Stands Out to Bull -- Market Talk

18 févr. 2026, 23:33 UTC

Market Talk

Gold Edges Higher Amid Growing Risks of U.S.-Iran Conflict -- Market Talk

18 févr. 2026, 23:32 UTC

Market Talk

Australia Jobs Data Will Likely Support May Hike Assumptions -- Market Talk

18 févr. 2026, 22:45 UTC

Résultats

DoorDash Stock Rebounds. Earnings and Revenue Both Fall Short. -- Barrons.com

18 févr. 2026, 22:44 UTC

Market Talk

Investors Eyeing Nvidia's Revenue Visibility Ahead of 4Q Print -- Market Talk

18 févr. 2026, 22:37 UTC

Résultats

Nutrien 4Q EPS $1.18 >NTR.T

18 févr. 2026, 22:37 UTC

Résultats

Nutrien 4Q Sales $5.34B >NTR.T

18 févr. 2026, 22:35 UTC

Résultats

Pan American Silver 4Q EPS $1.07 >PAAS

18 févr. 2026, 22:35 UTC

Résultats

Pan American Silver 4Q Rev $1.18B >PAAS

18 févr. 2026, 22:30 UTC

Résultats

Kinross Gold Raises Quarterly Dividend to 4c Vs. 3.5c >K.T

18 févr. 2026, 22:29 UTC

Résultats

Kinross Gold 4Q EPS 75c >K.T

18 févr. 2026, 22:22 UTC

Résultats

Coeur Mining: Full-Yr 2026 Production Is Expected to Be 55,000 - 65,000 Ounces of Gold and 5.5M - 6.3M Ounces of Silver >CDE

18 févr. 2026, 22:22 UTC

Market Talk

Nvidia 4Q Earnings Coming Amid China Export Battle -- Market Talk

18 févr. 2026, 22:16 UTC

Résultats

Brambles Raises Dividend, Cash-Flow Guidance as 1H Profit Jumps -- Update

18 févr. 2026, 22:05 UTC

Résultats

Pan American Silver Reports Record Fourth Quarter And Full Year 2025 Financial Results; Record Cash Flow From Operations Of $554 Million In The Fourth Quarter; Dividend Increased By 29% >PAAS

18 févr. 2026, 22:03 UTC

Résultats

Kaiser Aluminum Expects to Improve Conversion Rev by 5% to 10% and Adj EBITDA by 5% to 15% for FY26 >KALU

18 févr. 2026, 22:02 UTC

Résultats

Kaiser Aluminum 4Q Adj EPS $1.53 >KALU

18 févr. 2026, 22:02 UTC

Résultats

Kaiser Aluminum 4Q Sales $929M >KALU

18 févr. 2026, 22:02 UTC

Résultats

Kaiser Aluminum 4Q EPS $1.68 >KALU

18 févr. 2026, 22:00 UTC

Résultats

Kinross Gold 4Q Adj EPS 67c >KGC

18 févr. 2026, 22:00 UTC

Résultats

Kinross Gold 4Q Sales $2.02B >KGC

18 févr. 2026, 21:56 UTC

Résultats

Wesfarmers Boosts Dividend After 1H Profit Rises -- Update

18 févr. 2026, 21:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

Comparaison

Variation de prix

ICU Medical Inc prévision

Objectif de Prix

By TipRanks

20.77% hausse

Prévisions sur 12 Mois

Moyen 175 USD  20.77%

Haut 175 USD

Bas 175 USD

Basé sur 1 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

1 ratings

1

Achat

0

Maintien

0

Vente

Score Technique

By Trading Central

137.16 / N/ASupport & Résistance

Court Terme

Very Strong Bullish Evidence

Moyen Terme

Bullish Evidence

Long Terme

Strong Bearish Evidence

Sentiment

By Acuity

103 / 351Classement par Soins de santé

Sentiment de l'Actualité

Indications Haussières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos ICU Medical Inc

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride and sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 and Plum Duo brands; ambulatory and syringe infusion hardware products; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform; LifeShield and PharmGuard medication infusion safety software; hemodynamic monitoring products; anesthesia systems and devices, breathing circuits, ventilation, respiratory, and specialty airway products; temperature management solutions; anesthesia/pain management trays and components; and professional services. The company's customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, including outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is based in San Clemente, California.
help-icon Live chat